Nextrials Pledges Support for ANSI's Latest Initiative

Nextrials Pledges Support for ANSI Harmonization Standards for Electronic Health Records and Clinical Trial Patient Documents

Nextrials Joins GlaxoSmithKline, Johnson & Johnson and other industry titans to support interoperability framework for healthcare and pharmaceutical research

San Ramon, CA-February 13, 2009-Nextrials, Inc., a leader in clinical research software and services, is one of the charter members to pledge support for the American National Standards Institute’s latest initiative to facilitate the use of electronic health information within global clinical research activities.   One of the industry’s leading proponents for the integration of electronic data capture technology and electronic health records platforms, ANSI began the initiative last year at the request of the U. S. Department of Health and Human services; Nextrials joined the effort to provide support and to help develop the emerging standard.
 
“Nextrials has played a significant role in developing the Clinical Data Acquisition Standards Harmonization Initiative (CDASH) within the Clinical Data Interchange Standards Consortium (CDISC) and the Retrieve Form for Data Capture (RFD) standards within the Integrating the Healthcare Enterprise (IHE) organization, along with other leaders of the ANSI work group,” explained James Rogers, CEO and co-founder of Nextrials. “Early on, we recognized the value of integrating electronic health records within clinical trial management systems, as it will deliver more ROI to our customers in areas such as patient recruitment, reduced study startup time and patient safety.”
 
Nextrials will be demonstrating the interoperability of its award-winning Prism® clinical trial management platform at several trade shows throughout 2009, including at the 10th Annual North America Connectathon, the healthcare industry’s largest interoperability testing event being held February 23-27 at the Hyatt Regency Chicago, the annual meeting of the Healthcare Information and Management Systems Society (HIMSS), being held April 4-8 at the McCormick Place, Chicago and the 45th Annual Meeting of the Drug Information Association (DIA), being held June 21-25 at the San Diego Convention Center.
 
ANSI is now seeking funding to continue its work to promote the development and adoption of a standard that advances the continuum of patient care through the use of electronic health records to further future research and clinical decisions.  In addition to Nextrials, some of the 27 organizations participating in the effort so far include Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, Hewlett Packard, Pfizer and Duke University.
 
About Nextrials, Inc.
Founded by pharmaceutical researchers in 1999, Nextrials offers today’s most novel products and services for speeding the delivery of life-saving drugs and medical devices to market.  Prism®, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,000 research sites to streamline the initiation and management of clinical trials.  The company is headquartered in the San Francisco Bay area.  For more information, visit www.nextrials.com or call 925-355-3000. A podcast by co-founder and CEO James Rogers on the incorporation of electronic health records into the clinical trial process is also available at http://pharmavoice.com/podcasts.